U.S. Cannabis Market is projected to be worth 119.79 billion by 2034 and is anticipated to surge at a CAGR of 11.77%.
Cannabis, often referred to as marijuana, weed, or pot, is a psychoactive substance derived from the cannabis plant. It has a rich history of usage, serving both medical and recreational purposes. For centuries, it has been utilized across diverse cultures, religions, and spiritual practices. The drug can be consumed in various ways, including smoking dried flowers, using extracts like hashish, or incorporating it into food and beverages. The legal status of cannabis varies widely around the world, with some nations and regions permitting its use for recreational or medicinal purposes, while others enforce strict prohibitions.
Drivers: The cannabis market in the United States is witnessing considerable growth, fueled by the increasing millennial population in key markets and a rise in investment towards the research and production of medical marijuana. This demographic transition, along with a growing acceptance of cannabis for therapeutic purposes, offers a significant opportunity for market growth. From providing relief through medical treatments to becoming popular in recreational products, cannabis is becoming an integral part of American culture, influencing healthcare, leisure activities, and local economies.
Challenges: The cannabis market encounters substantial challenges due to stringent regulatory frameworks and varying legal statuses across different regions. While certain countries and states have legalized cannabis for medical or recreational use, many others still enforce strict prohibitions. Even in areas where it is legal, taxation policies, intricate licensing requirements, and compliance costs create obstacles for market participants. These challenges hinder market entry for smaller enterprises and impede the growth of cannabis-related products.
Market Trends: The cannabis sector is experiencing significant growth due to the rising acceptance of cannabis for both medical and recreational purposes. In the majority of U.S. states, cannabis has only been legalized for medical applications, with expectations for adult use legalization during the projected period. These legal changes enable the government to attempt to reduce the illegal marijuana market while focusing on generating considerable tax revenue from cannabis products. Furthermore, there is a strong demand for a variety of CBD-infused items, including cannabis oil, beauty products, gummies, beverages, capsules, and more. CBD can be absorbed by the human body through various methods, such as smoking, vaping, and topical application. In U.S. states where cannabis is permitted, it is used to manufacture personal care items and medical pharmaceuticals. The legalization of cannabis-based products has created substantial opportunities for different end-use sectors to broaden their product lines.
U.S. Cannabis Market Key Players:
Medical Marijuana, Inc, NuLeaf Naturals, LLC, CV Sciences, Inc, CHARLOTTE’S WEB, The Cronos Group, Organigram Holding, Inc, Irwin Naturals, Tilray Brands, Canopy Growth Corporation, and Aurora Cannabis are just a few of the major market players that are thoroughly examined in this market study along with revenue analysis, market segments, and competitive landscape data.
U.S. Cannabis Market Segmentation:
By Source: Based on the Source, U.S. Cannabis Market is segmented as; Hemp, Marijuana.
By Derivatives: Based on the Derivatives, U.S. Cannabis Market is segmented as; CBD, THC.
By Cultivation: Based on the Cultivation, U.S. Cannabis Market is segmented as; Indoor Cultivation, Greenhouse Cultivation, Outdoor Cultivation.
By End User: Based on the End User, U.S. Cannabis Market is segmented as; Industrial Use, Medical Use, Recreational Use.
By Region: This research also includes data for Northeast, Midwest, West, South.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.